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Summary.-Lymphocytes from a total of 161 subjects, including normal controls and
patients with malignant and non-malignant conditions, have been investigated
for their response to myelin basic protein, using the macrophage electrophoretic
mobility (MEM) test. It hasbeen confirmed thatthere was ahigh level ofassociation
between clinically evident cancer and a positive response. Lymphocytes from
24/45 patients with non-malignant inflammatory and ischaemic diseases also gave
positive responses. In 46 patients with breast lumps studied before mastectomy or
biopsy, the test was positive in 15/19 cases which proved to be malignant and in 5/27
which proved benign on histological examination.
In its present form the test is not sufficiently reliable for the diagnosis of early
cancer. Our results suggest that tissue necrosis in malignant and non-malignant
conditions may be one of the factors resulting in sensitization to antigenic de-
terminants present in preparations of myelin basic protein. Despite its technical
difficulties, the test may provide a means of examining some aspects of immune
recall not readily revealed by other test systems.
DIENGDOH AND TURK (1968) demon-
strated a marked decrease in the electro-
static charge of peritoneal macrophages
from tuberculin-sensitive guinea-pigs after
challenge with tuberculin. They found
that the effect was immunologically
specific but did not appear to be de-
pendent on the reaction of antigen and
circulating antibody occurring on the cell
surface. The macrophage electrophoretic
mobility (MEM) test ofField and Caspary
(1970) was based on these observations,
and was claimed to demonstrate changes
in the net electronegative surface charge
of guinea-pig peritoneal macrophages,
following incubation with culture media
containing lymphocytes and a previously
encountered antigen. The variety ofanti-
gens reported to have been studied in the
system is still very limited, but particular
interest arose from the report of Field
and Caspary (1970) that lymphocytes
from cancer patients respond to a histone-
like substance extractable from human
brain and known as encephalitogenic
factor (EF), a myelin basic protein
(MBP) preparation. Later reports
(Caspary and Field, 1971) have described
similar or more marked results, using
" cancer basic protein " (CaBP), an ex-
tract obtained by an analogous procedure
from a variety ofhuman tumours.
The original observations were con-
firmed by Pritchard et al. (1972, 1973)
using similar methods. These workers
also used a modification whereby lympho-
cytes were first incubated with antigen
and then removed by centrifugation and
the guinea-pig macrophages added to the
supernatant. Goldstone, Kerr and Irvine
(1973) and Preece and Light (1974)
studied small groups of patients, and
reported similar findings, although the
latter used a different technique for the
mobility measurements. Muller et al.
(1975) investigated the effect of several
antigens, including potassium chloride
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reported that responses tended to be
specific for extracts from the histological
type of tumour corresponding to that of
the lymphocyte donor. Lewkonia, Kerr
and Irvine (1974), however, were unable
to obtain the same degree of reliability
reported by other groups, particularly
when using a modification of the method
described by Pritchard et al. (1973), and
they suggested that, in its present form,
it was unsuitable for clinical application.
Others have reported that macrophage
slowing was not observed under the
conditions of the test (personal com-
munication).
MATERIALS AND METHODS
Ten to 15 ml of blood was collected
from groups of patients and normal healthy
hospital staff, some of whom were heavy
smokers (30 +/day). The patients selected
were suffering from cancer, or non-malignant
conditions where there was an acute or
chronic inflammatory process or ischaemia,
or varicose veins without ulceration. A
group of 46 women who had presented to a
breast clinic with early lesions of unknown
morphology at the time of testing was also
studied, and the results recorded before
mastectomy or biopsy.
To assess the reproducibility of the test,
5 normal women and 5 with eaily breast
cancer were studied on a double-blind basis
on two separate occasions.
Blood was taken with lightly siliconized
syringes and transferred into Repelcote-
treated (Repelcote, Hopkin & Williams Ltd,
Chadwell Heath, Essex, England) glass
universal containers containing 5 glass beads
(3.5A45 cm diam), and carefully defibrinated
to avoid haemolysis. Lymphocytes were
isolated, using a Ficoll-Triosil density
gradient, washed x 3 in medium 199
(Gibco) prepared in de-ionized water and
stored overnight at 40C in autologous
serum. Before incubation with antigen, they
were washed x 3 in medium 199 and re-
suspended at a concentration of 106 viable
cells/ml. Viability was assessed by trypan
blue dye exclusion.
Macrophages were obtained from the
peritoneal exudate of female ex-breeder
Hartley albino guinea-pigs (800 g), approxi-
mately 14 days after the injection of 20 ml
of sterile liquid paraffin. They were
harvested into Hanks' solution containing
5 u/ml of preservative-free heparin, washed
once in Hanks'/heparin and twice in medium
199, and then resuspended at a concentration
of 107/ml. The preparations were irradiated
with 200 rad. Myelin basic protein (MBP)
prepared bythe method ofDeibler, Masterson
and Kies (1972) was used as the antigen, at a
concentration of33 ,tg/ml. The preparations
showed heterogeneity on electrophoresis.
The method of incubation was essentially
that described by Pritchard et at. (1973):
106 lymphocytes were incubated with 66 ,ug
MBP in 2-0 ml of medium 199 at room temp-
erature for 90 min. Control tubes contained
the same number of lymphocytes but no
MBP. The lymphocytes were then removed
by centrifugation, and 107 macrophages
added to the supernate and incubated at
370C for a further 90 min. Ifnecessary, the
pH was adjusted to about 7-2 with bicarbo-
nate during the second incubation. Macro-
phage mobilities were measured in a cyto-
pherometer (Carl Zeiss (Oberkochen) Ltd,
31-36 Foley Street, London) at 230C ±
0.50Cand a potential of 180-200 V 9-5 mA.
Measurements were made on the same
macrophage in both directions and only
paired measurements agreeing to within
10% were accepted. Mobility measurements
were recorded, as described by Pritchard
et al. (1973) in 2 columns as " slow " and
" fast " cells, a slow cell under our conditions
taking > 3 0 s to migrate across one square
of the eyepiece grid. Cells were timed until
10 paired measurements fell into either the
" slow " or the " fast " column: if 5 or more
cells fell into the alternative column the
test was invalid. It was exceptional for
more than 2-3 cells to fall into the alternative
column. This procedure has been widely
used in order to exclude cells with mobilities
which are non-typical, but it has the effect of
exaggerating the measured response, which
we think is undesirable. Each test was done
with and without antigen, and a further
control of macrophages and antigen was
included with each batch. Batches of
irradiated macrophages which did not show
mean migration times in the range of2-75-2-9
before incubation were not used. Before
measurements were made, the samples were
coded and mixed, so that the test was
performed without the operator knowing the
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source of the samples, or which contained
antigen.
Results were expressed as the percentage
slowing relative to the control macrophage
migration time, M1 (no antigen present)
when measured following incubation with the
supernatantfromlymphocyte-MBPincubates,
M2.
M2_M1 x 100
In conformity with previous workers, a
slowing of migration times in excess of a
fixed value was scored as a positive response.
On the basis of our early tests we adopted a
value of > 12%.
RESULTS
Incubation of macrophages with anti-
gen alone had no effect on migration time:
similarly there was no effect on migration
time when macrophages were incubated
with lymphocytes in the absence of
antigen.
The results of the reproducibility
tests are shown in Table I.
Consistent results were obtained in
9 of the 10 duplicated experiments.
The one exception, a normal control (8)
was positive (18 7% slowing) on one
occasion but negative (- 2.2%) on the
other. A third test on this subject was
also negative. The reason for this
anomaly is not known.
The results of tests on 115 subjects
are summarized in Table II. Fig. 1
shows the distribution of the migration
times. A group of 20 patients with
various carcinomas was found to give
macrophage-slowing values of 12% or
more, and this value was taken as the
lowest limit of a " positive " result.
The higher values for macrophage slowing
reported by Pritchard et at. (1973) were
found only occasionally. Evaluated in
this way, the distribution ofslowing times
following incubation with MBP was bi-
modal. Mean values of 1.2% (s.d. =
0.02) and 14% (s.d. = 1.96) were obtained
for the group without evidence of malig-
nant disease. For the group with
carcinoma, the mean slowing time was
16.6% (s.d. = 0.48).
Patients with acute or chronic non-
malignant conditions had a greater scatter
of values in the negative range than the
normal subjects and 24/45 had positive
results (Fig. 1).
TABLE I.-Reproducibility Tests
Mean migration time(s)
Sample
IA
B
2A
B
3A
B
4A
B
5A
B
6A
B
7A
B
8A
B
9A
B
IOA
B
No MBP
2-76
2-77
2-76
2-74
2-78
2-79
2-79
2-79
2-74
2-72
2-70
2-72
2-71
2-72
2-72
2-78
2-79
2-74
2-81
2-79
S.d.
0 05
0-06
0-08
0-08
0 07
009
009
0-08
0-10
009
0 07
0 06
0-06
0-08
0 07
0-08
0-06
0 09
0-06
0 07
MBP
present
2*78
2-77
2-78
2-76
3 -22
3-15
3-21
3-18
3-14
3-17
2 72
2-79
2-70
2-70
3 -23
2-72
2*79
2-72
2-76
2-76
S.d.
0 05
0*06
0-08
0-08
0 08
0-10
0-10
0 09
0-10
0-10
0 07
0-06
0-07
0 08
0-08
0-08
0-06
009
0-08
0 07
A and B = 1st and 2nd measurement respectively. Coefficient
migration time is the mean of 20 measurements.
42
% Slowing
with MBP
0 7
0
0 7
0 7
1525 breast cancerpatients
15-0
14-0
14-5
16-5
0 7
2-3
-0*4
-0-7
-272 normal subjects
0
-0 7
-1*8 -1*0
of correlation (r) = 0-63. Each
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TABLE II.-Results of MEM Test in 115 Subjects with Malignant Disease,
Non-malignant Disease and No Known Disease
Group
A No known illness
Normal controls
Varicose veins
Heavy smokers
Total
B Non-neoplastic
Rheumatoid arthritis
Dermatomyositis
Acute appendicitis
Peripheral vascular disease
Myocardial infarction
Total
C Tumoumr
Trophoblastic tumours
Reticulum cell sarcoma
Carcinoma (various)
Total
No. Pos. Neg. % Positive
10
8
11
29
19
2
4
9
11
45
18
3
20
41
1*
0
2
3
8
2
8
4
24
16
3
20
39
9
8
9
26 }
11I)
2
1 7
7
21
2**
O
O
2
10
52
95
* Negative on repeating on 2 occasions (same case as in reproducibility tests).
** Invasive hydatidiform mole.
Using the x2 test groups A and C differ significantly from the total population
studied (P<0*001). Groups A B C differ significantly from each other (P<O*001).
On testing 46 patients with lumps in
the breast, 20 were found to be positive
and 26 to be negative. Subsequent
histological examination revealed that in
19 patients the lumps were malignant,
and the lymphocytes from 15 of these
patients were positive in the test: 27
patients proved to have benign disorders,
and 5 of these gave positive responses.
The migration times are shown in Fig. 2.
. 0*
* " GM_ *
0 0 * so 0
. 0
a
0 .
0
* *
I I I
0 3 6 9 12 15 18+
%slowing
FIG. 1.-Distribution of migration times from a study of 115 patients.
* a I
Myocardial
infarct
Peripheral
vascular
disease
Varicose
veins
Rheumatoid
arthritis
Heavy
smokers
Normal
Carcinoma
(various)
Trophoblastic
tumours
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FIG. 2. Distribution of migration times ob-
tained when applying the " slow " and
" fast " cell recording method, from 46
women with breast lumps.
DISCUSSION
The results in this study are broadly
consistent with the observations of Field
and Caspary (1970). The migration of
macrophages in an electrical field was
slowed following incubation with the
supernatant fluid from some reactions
between lymphocytes and a myelin basic
protein preparation. It is clear that, as
defined here, a positive result was un-
common (1/19) in normal subjects, and in
patients with varicose veins, whereas
positive results were obtained in all 39
patients with clinically evident malignant
tumours. Our results also confirm that
positive results are obtained in various
non-malignant conditions, including
inflammatory processes. These observa-
tions are extended by finding a high
proportion ofpositive responses in patients
with peripheral arterial disease or recent
myocardial infarction. The bimodal dis-
tribution of slowing values (Figs. 1 and 2)
is exaggerated by the method ofrecording
measurements used here, but even when
values arerecorded without this (Fig. 3)the
data still suggest that subjects are either
"sensitized" to MBP or they are not.
The value of the MEM test in its
present form, in the diagnosis of early
cancer would seem to be limited. In
patients with breast lumps examined
before surgical intervention, the test was
correct in only 80% of cases. It is
0 0 0 *4 4..
oIg5g I0 I0 0 0
0 4 8 12 16 20
%sloaing
Fie. 3. Distribution of migration times ob-
tained without applying the " slow " and
" fast " cell recording method, from 46
women with breast lumps.
possible that repeated tests or improved
sensitivity might improve its predictive
value, but it seems unlikely that this
would reach an adequate level of re-
liability. The test cannot be regarded
as being clinically applicable in its present
form, if only because of the technical
difficulty in its performance. Although
the test is reproducible under favourable
conditions, it is liable to give false positive
results. Ifhowever these difficulties were
overcome, a test of this type might have
some clinical value in the patientsuspected
of having a tumour, but lacking localizing
signs or other diagnostic features which
allowed the diagnosis to be established.
Why the lymphocytes of patients
with cancer respond to MBP in the MEM
test is not known. It has been suggested
(Mitchell, 1973) that autosensitization
may occur when histones or other basic
proteins are released in a " free solution "
form under conditions of anoxic necrosis.
It seems more likely that the antigen is a
non-specific product of necrosis in either
cancer or non-cancerous tissues, than an
antigen common to most forms of cancer,
but the latter possibility cannot be fully
excluded on present evidence.
The phenomenon underlying the MEM
test is interesting for several reasons.
It has been described as a test for
sensitization to antigens, but its relation-
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ship to other sensitization tests had not
been adequately defined. Light, Preece
and Walden (1975) obtained positive
results with the macrophage migration
inhibition test, using MBP and CaBP
preparations, but it is not clear whether
they found the MMI test more or less
reproducible than the MEM test. The
chemical and antigenic nature of the
preparations of MBP and of CaBP used
in the MEM test have not been adequately
defined and, as used here, MBP is a
heterogenous preparation. The possibility
that non-specific changes in the plasma
of patients with malignant and non-
malignant disorders, have a selective
effect on the population of lymphocytes
collected byFicoll-Triosil densitygradient,
requires consideration, but seems un-
likely, in view of the long persistence of
sensitization reported by Field (1972).
The short incubation times required
indicate that, whatever form antigen reco-
gnition takes in theMEMtest,theresponse
observed is much more rapid than that in
conventional tests for lymphocyte re-
activity. Yet the MEM test cannot be
regarded as highly sensitive in terms of
antigen concentration, since the con-
centration of MBP required is of the
order of 30 mg/I. It is possible that it
detects sensitization in only a small
fraction of the total lymphocyte popula-
tion. Although the question whether the
test relates to immunological recognition
has not been formally studied here, it is
submitted that the weight of evidence
suggests that it is dependent upon im-
munological recall processes. The lack of
specificity of the MEM test for cancer,
and the technical difficulties ofperforming
cell electrophoresis with guinea-pig perito-
neal macrophages, should not obscure the
potential value of the method as a means
for detecting immunological events not
accessible at present to other test systems.
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